AMAM — Ambrx Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Ambrx Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15.5	90.5	170	84.5
Net Total Accounts Receivable
Net Total Receivables	1.39	0.982	1.34	2.05
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18.2	93.1	177	90.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.97	3.49	15.7	14
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	61.7	134	229	147
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.9	13.3	24.6	16.7
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	28.3	20.4	39.1	29.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	33.4	114	190	118
Total Liabilities & Shareholders' Equity	61.7	134	229	147
Total Common Shares Outstanding